NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

中國的Tiotropium溴化物市場分析(2021年∼2025年)

Investigation Report on China's Tiotropium Bromide Market 2021-2025

出版商 China Research and Intelligence 商品編碼 1008268
出版日期 內容資訊 英文 50 Pages
商品交期: 最快1-2個工作天內
價格
中國的Tiotropium溴化物市場分析(2021年∼2025年) Investigation Report on China's Tiotropium Bromide Market 2021-2025
出版日期: 2021年05月28日內容資訊: 英文 50 Pages
簡介

Tiotropium溴化物是Boehringer Ingelheim International GmbH所開發的,慢性阻塞性肺病(COPD)的治療藥。其產品 "SPIRIVA" ,2006年在中國核可。2017年,Tiotropium溴化物吸入粉劑納入國家醫保目錄。2021上半年,Boehringer Ingelheim International GmbH,Nanchang Hongyi Pharmaceutical,Chia Tai Tianqing Pharmaceutical Group,Zhejiang Xianju Pharmaceutical進入中國的Tiotropium溴化物市場。

中國的Tiotropium溴化物的銷售量從2016年到2019年增加。特別,2017年被保險適用後,其銷售額順利成長。可是,受到新型冠狀病毒感染疾病(COVID-19)的影響,2020年的銷售量前一年同期比較減少19.3%成為2億7,400萬人民幣。從2016年到2020年的年複合成長率記錄4.73%。

本報告提供中國的Tiotropium溴化物市場相關調查,產品概要,新型冠狀病毒感染疾病(COVID-19)的影響,中國整體及各地區的銷售趨勢,製藥企業的市場佔有率,銷售額及銷售額數,價格趨勢,市場預測,市場成長要素,市場機會,課題等彙整資料。

目錄

第1章 Tiotropium溴化物概要

  • Tiotropium溴化物的適應症
  • 中國的Tiotropium溴化物的開發
  • 中國的Tiotropium溴化物的政府核准
  • 新型冠狀病毒感染疾病(COVID-19)對銷售的影響

第2章 中國的Tiotropium溴化物的銷售趨勢(2016年∼2020年)

  • Tiotropium溴化物的銷售額
    • 銷售額:全體
    • 銷售額:各地區
  • Tiotropium溴化物的銷售額數
    • 銷售額數:全體
    • 銷售額數:各地區
  • Tiotropium溴化物的銷售趨勢:各劑型
    • 氣體、粉末、氣霧劑
    • 吸引藥

第3章 中國的主要Tiotropium溴化物製造企業(2016年∼2020年)

  • 主要企業的市場佔有率
    • 銷售額
    • 銷售額數
  • Boehringer Ingelheim International GmbH
    • 企業概要
    • 中國的SPIRIVA的銷售額
  • Nanchang Hongyi Pharmaceutical Co., Ltd
    • 企業概要
    • 中國的Hongmingrui的銷售額
  • Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
    • 企業概要
    • 中國的Tianqingsule的銷售額
  • Zhejiang Xianju Pharmaceutical Co.,Ltd.
    • 企業概要
    • 中國的 Biduoyi的銷售額

第4章 中國的Tiotropium溴化物的價格(2020年∼2021年)

  • Boehringer Ingelheim International GmbH (SPIRIVA)
  • Nanchang Hongyi Pharmaceutical Co., Ltd. (Hongmingrui)
  • Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (Tianqingsule)
  • Zhejiang Xianju Pharmaceutical Co.,Ltd. (Biduoyi)

第5章 中國的Tiotropium溴化物市場預測(2021年∼2025年)

  • 市場發展的影響要素
    • 新型冠狀病毒感染疾病(COVID-19)的影響
    • 市場成長要素和機會
    • 市場威脅與課題
  • 市場規模的預測
  • 市場趨勢的預測
目錄
Product Code: 2105503

Tiotropium Bromide, developed by Boehringer Ingelheim International GmbH, is used to treat chronic obstructive pulmonary disease (COPD). Its product SPIRIVA was approved in China in 2006. In 2017, Tiotropium Bromide inhalation powder was included in the national medical insurance catalog. By the first half of 2021, in addition to Boehringer Ingelheim International GmbH, there are Nanchang Hongyi Pharmaceutical Co., Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., and Zhejiang Xianju Pharmaceutical Co., Ltd. in China's Tiotropium Bromide market.

According to CRI's market research, the sales of Tiotropium Bromide in the Chinese market have been on the rise from 2016 to 2019. Especially after the inhalation powder of Tiotropium Bromide was included in the national medical insurance catalog in 2017, its sales have grown steadily from 2017 to 2019. However, its sales fell 19.3% year-on-year to CNY274 million in 2020. The main reason for the decline in its sales is that the COVID-19 epidemic has impacted the hospital's overall diagnosis and treatment business. The CAGR of Tiotropium Bromide in the Chinese market from 2016 to 2020 is 4.73%.

CRI predicts that with the effective alleviation of the COVID-19 epidemic, the sales volume of Tiotropium Bromide in the Chinese market from 2021 to 2025 will have a restorative growth, promoting the increase in sales. As of the end of 2020, the number of chronic resistance disease patients in China has increased to more than 100 million. Therefore, the sales of Tiotropium Bromide will continue to grow, promoting the growth of the Tiotropium Bromide market.

Topics Covered:

  • The impact of COVID-19 on China's Tiotropium Bromide market
  • Sales value of China's Tiotropium Bromide 2016-2020
  • Competitive landscape of China's Tiotropium Bromide market
  • Prices of Tiotropium Bromide in China
  • Prices of Tiotropium Bromide in China by regions and manufacturers
  • Analysis on factors affecting the development of China's Tiotropium Bromide market
  • Prospect of China's Tiotropium Bromide market from 2021 to 2025

Table of Contents

1 Relevant Concepts of Tiotropium Bromide

  • 1.1 Indications for Tiotropium Bromide
  • 1.2 Development of Tiotropium Bromide in China
  • 1.3 Governmental Approval of Tiotropium Bromide in China
  • 1.4 The Impact of COVID-19 on Tiotropium Bromide sales in China

2 Sales of Tiotropium Bromide in China, 2016-2020

  • 2.1 Sales Value of Tiotropium Bromide
    • 2.1.1 Overall Sales Value
    • 2.1.2 Sales Value by Region
  • 2.2 Sales Volume of Tiotropium Bromide
    • 2.2.1 Overall Sales Volume
    • 2.2.2 Sales Volume by Region
  • 2.3 Sales of Tiotropium Bromide by Dosage Form in China, 2016-2020
    • 2.3.1 Gas (Powder) Aerosol
    • 2.3.2 Inhalation Power

3 Analysis of Major Tiotropium Bromide Manufacturers in China, 2016-2020

  • 3.1 Analysis of Market Share of Major Tiotropium Bromide Manufacturers
    • 3.1.1 Investigation on Market Share by Sales Value
    • 3.1.2 Investigation on Market Share by Sales volume
  • 3.2 Boehringer Ingelheim International GmbH
    • 3.2.1 Enterprise Profile
    • 3.2.2 Sales of SPIRIVA (Boehringer Ingelheim International GmbH's Tiotropium Bromide) in China
  • 3.3 Nanchang Hongyi Pharmaceutical Co., Ltd.
    • 3.3.1 Enterprise Profile
    • 3.3.2 Sales of Hongmingrui (Nanchang Hongyi Pharmaceutical Co., Ltd.'s Tiotropium Bromide) in China
  • 3.4 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
    • 3.4.1 Enterprise Profile
    • 3.4.2 Sales of Tianqingsule (Chia Tai Tianqing Pharmaceutical Group Co., Ltd.'s Tiotropium Bromide) in China
  • 3.5 Zhejiang Xianju Pharmaceutical Co.,Ltd.
    • 3.5.1 Enterprise Profile
    • 3.5.2 Sales of Biduoyi (Zhejiang Xianju Pharmaceutical Co.,Ltd.'s Tiotropium Bromide) in China

4 Prices of Tiotropium Bromide for Different Manufacturers in China, 2020-2021

  • 4.1 Boehringer Ingelheim International GmbH (SPIRIVA)
  • 4.2 Nanchang Hongyi Pharmaceutical Co., Ltd. (Hongmingrui)
  • 4.3 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (Tianqingsule)
  • 4.4 Zhejiang Xianju Pharmaceutical Co.,Ltd. (Biduoyi)

5 Prospect of Chinese Tiotropium Bromide Market, 2021-2025

  • 5.1 Influential Factors of Chinese Tiotropium Bromide Market Development
    • 5.1.1 The Impact of COVID-19 on Chinese Tiotropium Bromide Market
    • 5.1.2 Market Drivers and Opportunities
    • 5.1.3 Market Threats and Challenges
  • 5.2 Forecast on Market Size
  • 5.3 Forecast on Market Trend

List of Charts

  • Chart Patent Information About Tiotropium Bromide Gas (Powder) Aerosol Registration in China
  • Chart Patent Information About Tiotropium Bromide Inhalation Power Registration in China
  • Chart Sales Value of Tiotropium Bromide Gas (Powder) Aerosol over the World
  • Chart Sales Value of Tiotropium Bromide Inhalation Power over the World
  • Chart Sales Value of Tiotropium Bromide Gas (Powder) Aerosol in China, 2016-2020
  • Chart Sales Value of Tiotropium Bromide Inhalation Power in China, 2016-2020
  • Chart Sales Value of Tiotropium Bromide Gas (Powder) Aerosol in China by Region, 2016-2020
  • Chart Sales Value of Tiotropium Bromide Inhalation Power in China by Region, 2016-2020
  • Chart Sales Volume of Tiotropium Bromide Gas (Powder) Aerosol in China, 2016-2020
  • Chart Sales Volume of Tiotropium Bromide Inhalation Power in China, 2016-2020
  • Chart Sales Volume of Tiotropium Bromide Gas (Powder) Aerosol in China by Region, 2016-2020
  • Chart Sales Volume of Tiotropium Bromide Inhalation Power in China by Region, 2016-2020
  • Chart Market Share by Sales Value of Top Tiotropium Bromide Gas (Powder) Aerosol Manufacturers in China, 2016-2020
  • Chart Market Share by Sales Value of Top Tiotropium Bromide Inhalation Power Manufacturers in China, 2016-2020
  • Chart Sales Value and Volume of SPIRIVA (Boehringer Ingelheim International GmbH's Tiotropium Bromide) in China, 2016-2020
  • Chart Sales Value and Volume of Hongmingrui (Nanchang Hongyi Pharmaceutical Co., Ltd.'s Tiotropium Bromide) in China, 2016-2020
  • Chart Sales Value and Volume of Tianqingsule in China, 2016-2020
  • Chart Sales Value and Volume of Biduoyi in China, 2016-2020
  • Chart Referential Prices of SPIRIVA in China by Region, 2020-2021
  • Chart Referential Prices of Hongmingrui in China by Region, 2020-2021
  • Chart Referential Prices of Tianqingsule in China by Region, 2020-2021
  • Chart Referential Prices of Biduoyi in China by Region, 2020-2021
  • Chart Forecast on Sales Value of Tiotropium Bromide Gas (Powder) Aerosol in China, 2021-2025
  • Chart Forecast on Sales Value of Tiotropium Bromide Inhalation Power in China, 2021-2025
  • Chart Forecast on Sales Volume of Tiotropium Bromide Gas (Powder) Aerosol in China, 2021-2025
  • Chart Forecast on Sales Volume of Tiotropium Bromide Inhalation Power in China, 2021-2025